Severe Bone Resorption

Drug	Drug Name	Drug Description
DB00169	Cholecalciferol	A form of Vitamin D used in the treatment of specific medical conditions such as refractory rickets, hypoparathyroidism, and familial hypophosphatemia, as well as osteoporosis and chronic kidney disease.

Drug	Drug Name	Target	Type
DB00169	Cholecalciferol	Vitamin D-binding protein	carrier
DB00169	Cholecalciferol	Cholesterol side-chain cleavage enzyme, mitochondrial	enzyme
DB00169	Cholecalciferol	Vitamin D 25-hydroxylase	enzyme
DB00169	Cholecalciferol	Sterol 26-hydroxylase, mitochondrial	enzyme
DB00169	Cholecalciferol	Cytochrome P450 2J2	enzyme
DB00169	Cholecalciferol	Cytochrome P450 3A4	enzyme
DB00169	Cholecalciferol	Vitamin D3 receptor	target
DB00169	Cholecalciferol	Cytochrome P450 1A1	enzyme
DB00169	Cholecalciferol	Cytochrome P450 2C8	enzyme

Drug	Drug Name	Phase	Status	Count